| fMRI in translation: the challenges facing real-world applications S Schleim, JP Roiser Frontiers in Human Neuroscience 3, 845, 2009 | 98 | 2009 |
| From moral to legal judgment: the influence of normative context in lawyers and other academics S Schleim, TM Spranger, S Erk, H Walter Social cognitive and affective neuroscience 6 (1), 48-57, 2011 | 79 | 2011 |
| Brains in context in the neurolaw debate: The examples of free will and “dangerous” brains S Schleim International Journal of Law and Psychiatry 35 (2), 104-111, 2012 | 67 | 2012 |
| Methodological problems on the way to integrative human neuroscience B Kotchoubey, F Tretter, HA Braun, T Buchheim, A Draguhn, T Fuchs, ... Frontiers in Integrative Neuroscience 10, 41, 2016 | 58 | 2016 |
| Die Neurogesellschaft: Wie die Hirnforschung Recht und Moral herausfordert S Schleim Heise Verlag, 2011 | 48* | 2011 |
| Gedankenlesen: Pionierarbeit der Hirnforschung S Schleim Heise Verlag, 2008 | 48* | 2008 |
| How realistic are the scientific assumptions of the neuroenhancement debate? Assessing the pharmacological optimism and neuroenhancement prevalence hypotheses S Schleim, BB Quednow Frontiers in Pharmacology 9, 3, 2018 | 42 | 2018 |
| Critical neuroscience—or critical science? A perspective on the perceived normative significance of neuroscience S Schleim Frontiers in Human Neuroscience 8, 336, 2014 | 38 | 2014 |
| Von der Neuroethik zum Neurorecht? S Schleim, TM Spranger, H Walter Vandenhoeck & Ruprecht, 2009 | 33 | 2009 |
| Whose well-being? Common conceptions and misconceptions in the enhancement debate S Schleim Frontiers in Systems Neuroscience 8, 148, 2014 | 32 | 2014 |
| Cognitive Enhancement–Sechs Gründe dagegen S Schleim Künstliche Sinne – Gedoptes Gehirn. Neurotechnik und Neuroethik, 2010 | 26 | 2010 |
| Zufallsfunde in der bildgebenden Hirnforschung S Schleim, T Spranger, H Urbach, H Walter Nervenheilkunde 26 (11), 1041-1045, 2007 | 25 | 2007 |
| Cognitive enhancement: Fakten und mythen S Schleim, H Walter Nervenheilkunde 26 (1-2), 83-86, 2007 | 25 | 2007 |
| Debunking the ethical neuroenhancement debate S Schleim, BB Quednow Rethinking cognitive enhancement, 164-176, 2017 | 22 | 2017 |
| Second thoughts on the prevalence of enhancement S Schleim BioSocieties 5 (4), 484-485, 2010 | 21 | 2010 |
| Real neurolaw in the Netherlands: The role of the developing brain in the new adolescent criminal law S Schleim Frontiers in Psychology 11, 1762, 2020 | 19 | 2020 |
| Dragee zum Glück S Schleim Könneker, Carsten (Hg.): Wer erklärt den Menschen, 222-228, 2005 | 16 | 2005 |
| Grounded in biology: why the context-dependency of psychedelic drug effects means opportunities, not problems for anthropology and pharmacology S Schleim Frontiers in Psychiatry 13, 906487, 2022 | 15 | 2022 |
| Neuroenhancement as instrumental drug use: Putting the debate in a different frame S Schleim Frontiers in Psychiatry 11, 567497, 2020 | 15 | 2020 |
| Why mental disorders are brain disorders. And why they are not: ADHD and the challenges of heterogeneity and reification S Schleim Frontiers in Psychiatry 13, 943049, 2022 | 14 | 2022 |
Boris B. QuednowProfessor Pharmakopsychologie, Universität ZürichVerified email at bli.uzh.ch
